tiprankstipranks
Unity Biotechnology Inc (UBX)
NASDAQ:UBX
US Market
Holding UBX?
Track your performance easily

Unity Biotechnology (UBX) Financial Statements

754 Followers

Unity Biotechnology Financial Overview

Unity Biotechnology's market cap is currently ―. The company's EPS TTM is $-1.319; its P/E ratio is ―; Unity Biotechnology is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 1.07M$ 1.47M$ 1.47M-$ 976.00K
Gross Profit$ 1.07M$ 1.47M$ 1.47M-$ 976.00K
EBIT$ -6.48M$ -5.28M$ -5.79M$ -1.50M$ -14.22M
EBITDA$ -6.26M$ -4.80M$ -5.56M$ -1.27M$ -14.51M
Net Income Common Stockholders$ -6.48M$ -5.28M$ -5.79M$ -1.50M$ -14.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 29.04M$ 33.98M$ 36.33M$ 43.20M$ 45.94M
Total Assets$ 47.13M$ 53.52M$ 58.86M$ 65.69M$ 69.27M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 32.99M$ 33.77M$ 34.88M$ 37.29M$ 33.06M
Stockholders Equity$ 14.14M$ 19.78M$ 24.03M$ 28.35M$ 36.22M
Cash Flow-
Free Cash Flow$ -5.19M$ -4.58M$ -5.16M$ -7.46M$ -7.12M
Operating Cash Flow$ -5.19M$ -4.58M$ -5.18M$ -7.58M$ -7.11M
Investing Cash Flow$ 6.51M$ 4.67M$ -7.19M$ 15.11M$ 14.25M
Financing Cash Flow-$ 68.00K-$ 4.39M$ -18.38M
Currency in USD

Unity Biotechnology Earnings and Revenue History

Unity Biotechnology Debt to Assets

Unity Biotechnology Cash Flow

Unity Biotechnology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis